Maurizio Chiriva Internati completed his Degree in Biological Sciences at the University of Milan, Italy and Doctorate of Immunology at the University of Nottingham, UK and morphological sciences at the University of Milan, Italy. He completed his Postdoctoral research on tumor immunology, virology and cancer vaccine studies from the University of Arkansas for Medical Sciences. Currently, he is the Director of Basic and Translational Research at the division on Hematology & Oncology at the Texas Tech University Health Sciences Center, School of Medicine, and is a senior editor for the journal, International Reviews of Immunology. He has published more than 100 papers in peer reviewed journals and serves as on the Editorial Board Member of several reputed cancer journals. Maurizio Chiriva Internati completed his Degree in Biological Sciences at the University of Milan, Italy and Doctorate of Immunology at the University of Nottingham, UK and morphological sciences at the University of Milan, Italy. He completed his Postdoctoral research on tumor immunology, virology and cancer vaccine studies from the University of Arkansas for Medical Sciences. Currently, he is the Director of Basic and Translational Research at the division on Hematology & Oncology at the Texas Tech University Health Sciences Center, School of Medicine, and is a senior editor for the journal, International Reviews of Immunology. He has published more than 100 papers in peer reviewed journals and serves as on the Editorial Board Member of several reputed cancer journals.

Vaccine, Immunology